Hansa Biopharma - Hansa Biopharma announces long term follow
-
Hansa Biopharma - Hansa Biopharma announces long term follow-up data demonstrating 3-year graft survival of 84% after imlifidase treatment and transplantation https://investors.hansabiopharma.com/English/press-releases/press-releases-details/2021/Hansa-Biopharma-announces-long-term-follow-up-data-demonstrating-3-year-graft-survival-of-84-after-imlifidase-treatment-and-transplantation/default.aspx
-
Har min tvivl....hver gang den stiger lidt, bliver den kørt ligeså hurtigt baglæns igen....Især MSE JPAG MLI MLEX trykker den nedad igen hver gang, man tror at trenden vender opad igen. Mit bud, måske en lille stigning om morgenen og så baglæns igen, desværre
-
Helt som forventet: Største sælgere: GSAG. -1898
JPAG. -3171
MLEX. -5854
SIS. -8132
MSE. -8324
De fortsætter med at pumpe kursen nedad.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind